Johnson & Johnson ordered to pay 572m dollars in opioid case

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"2">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p>A judge in Oklahoma has found Johnson &amp&semi; Johnson and its subsidiaries helped fuel the state’s opioid crisis and ordered the consumer products giant to pay 572 million US dollars&period;<&sol;p>&NewLine;<p>Cleveland County District Judge Thad Balkman’s ruling followed the first state opioid case to make it to trial and could help shape negotiations over roughly 1&comma;500 similar lawsuits filed by state&comma; local and tribal governments consolidated before a federal judge in Ohio&period;<&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;The opioid crisis has ravaged the state of Oklahoma&comma;”<&sol;em> Mr Balkman said before announcing the verdict&period;<&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;It must be abated immediately&period;”<&sol;em><&sol;p>&NewLine;<p>The companies are expected to appeal against the ruling to the Oklahoma Supreme Court&period;<&sol;p>&NewLine;<p>Before Oklahoma’s trial began on May 28&comma; Oklahoma reached settlements with two other defendant groups — a 270 million-dollar &lpar;£221m&rpar; deal with OxyContin-maker Purdue Pharma and an 85 million-dollar &lpar;£69m&rpar; settlement with Israeli-owned Teva Pharmaceutical Industries Ltd&period;<&sol;p>&NewLine;<p>Oklahoma argued the companies and their subsidiaries created a public nuisance by launching an aggressive and misleading marketing campaign that overstated how effective the drugs were for treating chronic pain and understated the risk of addiction&period;<&sol;p>&NewLine;<p>Oklahoma Attorney General Mike Hunter says opioid overdoses killed 4&comma;653 people in the state from 2007 to 2017&period;<&sol;p>&NewLine;<p>Mr Hunter has called Johnson &amp&semi; Johnson a &OpenCurlyDoubleQuote;kingpin” company that was motivated by greed&period;<&sol;p>&NewLine;<p>He specifically pointed to two former Johnson &amp&semi; Johnson subsidiaries&comma; Noramco and Tasmanian Alkaloids&comma; which produced much of the raw opium used by other manufacturers to produce the drugs&period;<&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;They’ve been the principal origin for the active pharmaceutical ingredient in prescription opioids in the country for the last two decades&comma;”<&sol;em> Mr Hunter said after the trial ended on July 15&period;<&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;It is one of the most important elements of causation with regard to why the defendants… are responsible for the epidemic in the country and in Oklahoma&period;”<&sol;em><&sol;p>&NewLine;<p>Lawyers for the company have maintained they were part of a lawful and heavily regulated industry subject to strict federal oversight&comma; including the US Drug Enforcement Agency and the Food and Drug Administration&comma; during every step of the supply chain&period;<&sol;p>&NewLine;<p>Lead lawyer Larry Ottaway said during closing arguments that opioid drugs serve a critical health need – to address chronic pain that affects thousands of Oklahomans every day&period;<&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;This problem of untreated chronic pain afflicts people here in Oklahoma&comma;”<&sol;em> Mr Ottaway said&period;<&sol;p>&NewLine;<p>Oklahoma pursued the case under the state’s public nuisance statute and presented the judge with a plan to abate the crisis that would cost between 12&period;6 billion dollars for 20 years and 17&period;5 billion dollars over 30 years&period;<&sol;p>&NewLine;<p>Lawyers for Johnson &amp&semi; Johnson have said that estimate is wildly inflated&period;<&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-68e275685a4ec">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-68e275685a4ec'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -
Exit mobile version